treatment rheumatoid arthriti monoclon antibodi effect treatment monoclon antibodi antigen present helper cell patient sever intract rheumatoid arthriti open trial monoclon antibodi dosag mg/kg bodi weight consecut day studi kinet drastic deplet cell low cells/microlit hour first infus subsequ recoveri cell number hour infus initi level full treatment cycl signific reduct number cell mean SD invers ratio week lymphocyt transform assay reactiv patient cours wherea individu unexpect elev cell respons mitogen common antigen parallel laboratori studi signific decreas erythrocyt sediment rate rheumatoid factor titer total immunoglobulin valu reduct c-reactiv protein level patient signific reduct ritchi articular index number swollen joint advers effect urticaria patient therapi chill fever suggest lymphokin releas syndrom patient low level human anti-mous immunoglobulin antibodi mg/liter possibl treatment cycl efficaci patient reduct ritchi index number swollen joint find treatment monoclon antibodi antigen result clinic benefit initi observ period month postinfus long-term remiss therapeut approach use immunosuppress therapi antibodi treatment 